F-star Therapeutics Q2 EPS $(0.92) Misses $(0.74) Estimate
F-star Therapeutics (NASDAQ: FSTX) reported quarterly losses of $(0.92) per share which missed the analyst consensus estimate of $(0.74) by 24.32 percent.F-star Therapeutics (NASDAQ:FSTX) reported quarterly losses of $(0.92) per share which missed the anal